Binge drinking

Clearmind Medicine CEO Issues Letter to Shareholders

Retrieved on: 
Tuesday, April 9, 2024

Recently, our efforts reached a key inflection point as the Israeli Ministry of Health approved our Phase I/IIa clinical trial for CMND-100 for AUD.

Key Points: 
  • Recently, our efforts reached a key inflection point as the Israeli Ministry of Health approved our Phase I/IIa clinical trial for CMND-100 for AUD.
  • CMND-100, a pioneering MEAI-based (5-methoxy-2-aminoindane) formula, has exhibited encouraging results in pre-clinical studies.
  • Notably, it has shown the ability to disrupt the destructive cycle of binge drinking without inducing hallucinations—a common concern with existing treatments.
  • The journey ahead is filled with potential, and we eagerly anticipate sharing impactful updates with our shareholders."

Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China

Retrieved on: 
Tuesday, March 19, 2024

Tel Aviv, Israel / Vancouver, Canada, March 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced that it has been granted divisional patent approval by the China National Intellectual Property Administration.

Key Points: 
  • The divisional patent approval, previously announced, grants Clearmind a broader claim than patent application.
  • This latest patent builds upon Clearmind’s broad IP protection in the psychedelic space, which now includes 27 granted patents and 24 pending patent applications across 15 patent families, nine of which have been granted in major jurisdictions such as the US, Europe, China, and India.
  • The granting of this latest patent establishes both the company's patent protection around its flagship molecule as well as its extensive IP protection in the psychedelic space.
  • Clearmind’s MEAI may also be used to treat binge drinking, which can be a deadly addiction for some.

Pernod Ricard Launches a New Digital Campaign for Its Flagship Responsible Drinking Initiative: DRINK MORE WATER

Retrieved on: 
Monday, March 18, 2024

As “Créateurs de Convivialité,” Pernod Ricard has a long-standing commitment to promoting responsible drinking in a meaningful and authentic way, and through this campaign has demonstrated its desire to always go a step further.

Key Points: 
  • As “Créateurs de Convivialité,” Pernod Ricard has a long-standing commitment to promoting responsible drinking in a meaningful and authentic way, and through this campaign has demonstrated its desire to always go a step further.
  • Built on Pernod Ricard’s historical prevention programme Responsible Party, launched in 2009, DRINK MORE WATER is a responsible drinking initiative tackling the issue of binge drinking among young adults.
  • The chosen messaging seeks to strengthen the role of water and its power to reduce alcohol harm within GenZ’s excessive behavioral patterns.
  • And because impact is what really matters, Pernod Ricard aims at reaching 1 billion young adults digitally by the end of 2025.

Why it’s a bad idea to mix alcohol with some medications

Retrieved on: 
Monday, February 12, 2024

But you may not be aware that mixing certain medicines with alcohol can increase the effects and put you at risk.

Key Points: 
  • But you may not be aware that mixing certain medicines with alcohol can increase the effects and put you at risk.
  • When you mix alcohol with medicines, whether prescription or over-the-counter, the medicines can increase the effects of the alcohol or the alcohol can increase the side-effects of the drug.
  • This is because there is less water in their bodies that can mix with the alcohol.
  • If you do want to drink alcohol while being on medication, discuss it with your doctor or pharmacist first.

HILDA survey at a glance: 7 charts reveal we’re smoking less, taking more drugs and still binge drinking

Retrieved on: 
Sunday, February 11, 2024

Australians’ vices, including drinking, smoking and illicit drugs, have been revealed in the latest HILDA survey.

Key Points: 
  • Australians’ vices, including drinking, smoking and illicit drugs, have been revealed in the latest HILDA survey.
  • The survey collects information on many facets of life and is the only study of its kind in Australia.
  • Indeed, HILDA shows that over 60% of people who quit smoking take it up again within three years.
  • Read more: HILDA data show women's job prospects improving relative to men's, and the COVID changes might have helped

HILDA data show women’s job prospects improving relative to men’s, and the COVID changes might have helped

Retrieved on: 
Sunday, February 11, 2024

The latest HILDA survey shows Australia’s gender gap in employment continuing to close, with progress beginning on the earnings gap.

Key Points: 
  • The latest HILDA survey shows Australia’s gender gap in employment continuing to close, with progress beginning on the earnings gap.
  • Remarkably, the progress has continued notwithstanding the disruptions caused by COVID; there are indications they may even have helped.

Employment lifting

  • For men of that age, the proportion in paid employment has changed little during those two decades, fluctuating between 80% and 84%, allowing the gap in employment between men and women to narrow eight percentage points.
  • Most of the gain has taken place since 2009 when one in ten women of that age were in paid employment, a figure that has since climbed to one in four, not too far off the one in three men of that age employed.
  • While men remain well ahead in full-time employment, that gap is narrowing too.
  • If the gender gap in employment is to be eliminated, it is clear couples with children will need to share the load more equally.

Wages lifting

  • In 2001, women employed full-time earned on average 79% of what men earned.
  • Average female earnings have climbed from 66% of male earnings in 2001 to 75% in 2021.

How COVID might have helped

  • HILDA shows the proportion of employees working from home in 2020 and 2021 has increased substantially.
  • The proportion working any hours at home climbed from 25.1% in 2019 to 37.3% in 2021.
  • There are health risks from working from home while unwell and also career risks from working at home.
  • “Out of sight” can mean “out of mind” when it comes to promotions.

Some small steps on sharing the caring

  • The improvement accelerated slightly in 2020 and 2021, via both an increase in the hours worked on domestic chores by men and a slight decrease for women.
  • In 2021, mothers of dependent children were still spending 75% more time on unpaid housework and child care than their male partners.


Roger Wilkins receives funding from the Australian Research Council.

Youth drinking is declining – myths about the trend, busted

Retrieved on: 
Tuesday, February 6, 2024

And with many pubs and cocktail bars now catering to the sober and “sober curious”, it’s easier than ever to opt out.

Key Points: 
  • And with many pubs and cocktail bars now catering to the sober and “sober curious”, it’s easier than ever to opt out.
  • The proportion of 16- to 24-year-olds who report drinking alcohol in the last week fell from 67% in 2002 to 37% in 2021.
  • We have been researching the decline in youth drinking in England and Australia, using both surveys and interviews with young people.

Why are young people drinking less?

  • From smoking to sex, young people – including those in early adolescence and in their early twenties – are generally more risk averse than previous generations.
  • Recent research shows that drinking has become less routine and expected for young people, while not drinking has become more socially acceptable.
  • However, it can’t be the only explanation, as in some countries where there has been a decline in youth drinking, policies regulating young people’s access to alcohol haven’t changed.

Misconceptions about youth drinking

  • But both of these – like the rise in teen vaping – occurred years after the decline in youth drinking was well-established.
  • And while the rise of the internet and social media happened at the same time as the drinking decline, there is little evidence that young people are using technology in place of drinking.
  • It is important to note that the decline in youth drinking is not the same as the growing “sobriety movement”.
  • Those who speak publicly about their decision to go sober usually describe how this decision was made after years of binge drinking.


Laura Fenton receives funding from Wellcome Trust (208090/Z/17/Z) for her research on the decline in youth drinking. Amy Pennay receives funding from the Australian Research Council, the National Health and Medical Research Council (Australia) and the Victorian Health Promotion Foundation. John Holmes receives funding from Wellcome (208090/Z/17/Z) for his research on the decline in youth drinking.

Clearmind Medicine Receives Patent Approval for its Psychedelic Based Treatment of Binge Behaviors in China

Retrieved on: 
Monday, February 5, 2024

The granting of this latest patent establishes both the company's patent protection around its flagship molecule as well as its extensive IP protection in the psychedelic space.

Key Points: 
  • The granting of this latest patent establishes both the company's patent protection around its flagship molecule as well as its extensive IP protection in the psychedelic space.
  • "We are proud to receive once again recognition of our innovative treatment for binge behaviors.
  • “In various pre-clinical studies, carried out during the past 2 years, MEAI has demonstrated its ability to regulate binge behaviors, addiction and other mental health disorders.
  • Clearmind’s MEAI may also be used to treat binge drinking, which can be a deadly addiction for some.

New Virtue Recovery Drug & Alcohol Rehab Center Opens in Killeen, TX to Serve the Local Community

Retrieved on: 
Monday, January 29, 2024

KILLEEN, Texas, Jan. 29, 2024 /PRNewswire-PRWeb/ -- Killeen, Texas, a vibrant city renowned for its military base (Ft Hood), aquatics park, and cultural diversity, has welcomed a crucial addition to its community resources - the recently opened Virtue Recovery Drug & Alcohol Rehab Center in Killeen. In the face of significant challenges related to drug and alcohol abuse, this state-of-the-art facility has emerged as a beacon of hope. Recent statistics have illuminated the extent of the issue, underscoring the pressing need for community awareness, prevention, and support, which are now being addressed by the center's comprehensive programs and dedicated staff.

Key Points: 
  • In response, the Killeen community has rallied together, welcoming the new Virtue Recovery Center in Killeen, a pivotal addition in their efforts to tackle these issues head-on.
  • KILLEEN, Texas, Jan. 29, 2024 /PRNewswire-PRWeb/ -- Killeen, Texas, a vibrant city renowned for its military base (Ft Hood), aquatics park, and cultural diversity, has welcomed a crucial addition to its community resources - the recently opened Virtue Recovery Drug & Alcohol Rehab Center in Killeen .
  • In the face of significant challenges related to drug and alcohol abuse, this state-of-the-art facility has emerged as a beacon of hope.
  • Our newly opened Drug & Alcohol Rehab Center is the beacon of hope Killeen needs to combat substance abuse effectively, in light of the concerning statistics.

Global Cardiac Bio Implant Devices Market Size and Forecast Report 2023: A $60+ Billion Industry by 2030 - Growing Attractiveness of Bio-implant Treatments Bolsters Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, January 15, 2024

The "Cardiac Bio Implant Devices Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cardiac Bio Implant Devices Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • Global Cardiac Bio-Implants Device Market size is estimated to be US$ 60.20 Billion by 2030.
  • The global cardiac bio-implants market changed into worth USD 34.70 Billion in 2022.
  • The growth of the Cardiac Catheterization laboratory market is primarily fueled by the increasing prevalence of cardiovascular disorders and advancements in Cardiac Catheterization lab technology.